Janssen HLA - Search Results

1

Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.

Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network. Feld JJ, et al. Among authors: janssen hla. Hepatology. 2019 Jun;69(6):2338-2348. doi: 10.1002/hep.30417. Epub 2019 Mar 14. Hepatology. 2019. PMID: 30549279 Free PMC article.

2

Suicide associated with alfa-interferon therapy for chronic viral hepatitis.

Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Janssen HL, et al. J Hepatol. 1994 Aug;21(2):241-3. doi: 10.1016/s0168-8278(05)80402-7. J Hepatol. 1994. PMID: 7989716

3

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.

Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Janssen HL, et al. Hepatology. 1993 Mar;17(3):383-8. Hepatology. 1993. PMID: 8444411 Clinical Trial.

4

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

5

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL. van Zonneveld M, et al. Hepatology. 2004 Mar;39(3):804-10. doi: 10.1002/hep.20128. Hepatology. 2004. PMID: 14999700

6

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Stoop JN, et al. Hepatology. 2005 Apr;41(4):771-8. doi: 10.1002/hep.20649. Hepatology. 2005. PMID: 15791617

7

The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.

Leemans WF, Flink HJ, Janssen HL, Niesters HG, Schalm SW, de Man RA. Leemans WF, et al. J Hepatol. 2006 Mar;44(3):507-11. doi: 10.1016/j.jhep.2005.12.004. Epub 2006 Jan 19. J Hepatol. 2006. PMID: 16457904

8

Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?

Buster EH, Janssen HL. Buster EH, et al. Neth J Med. 2006 Jun;64(6):175-85. Neth J Med. 2006. PMID: 16788215 Free article. Review.

9

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.

ter Borg MJ, van Zonneveld M, Zeuzem S, Senturk H, Akarca US, Simon C, Hansen BE, Haagmans BL, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group. ter Borg MJ, et al. Hepatology. 2006 Sep;44(3):721-7. doi: 10.1002/hep.21302. Hepatology. 2006. PMID: 16941701 Clinical Trial.

10

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.

Buster EH, Hansen BE, Buti M, Delwaide J, Niederau C, Michielsen PP, Flisiak R, Zondervan PE, Schalm SW, Janssen HL; HBV 99-01 Study Group. Buster EH, et al. Hepatology. 2007 Aug;46(2):388-94. doi: 10.1002/hep.21723. Hepatology. 2007. PMID: 17604363 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

554 results

Search Page